首页> 外文OA文献 >Dipeptide cis-cyclo(Leucyl-Tyrosyl) produced by sponge associated Penicillium sp. F37 inhibits biofilm formation of the pathogenic Staphylococcus epidermidis.
【2h】

Dipeptide cis-cyclo(Leucyl-Tyrosyl) produced by sponge associated Penicillium sp. F37 inhibits biofilm formation of the pathogenic Staphylococcus epidermidis.

机译:由海绵相关的青霉属sp生产的二肽顺式-环(亮氨酰-酪氨酰)。 F37抑制致病性表皮葡萄球菌的生物膜形成。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

Infections associated to microbial biofilms are involved in 80% of human infections and became a challenge concerning public health. Infections related to Staphylococcus epidermidis biofilms are presently commonly associated to medical devices, increasing treatment costs for this type of infection. Alternatives to eliminate this kind of disease have been employed in screening programs using diverse marine-derived fungi source of bioactive compounds capable to combat biofilm formation. In this work was isolated the dipeptide cis-cyclo(Leucyl-Tyrosyl) from a sponge associated Penicillium sp. possessing a remarkable inhibition up to 85% of biofilm formation without interfering with bacterial growth, confirmed by scanning electron microscopy. This is the first demonstration that cis-cyclo(Leucyl-Tyrosyl) is able to specifically inhibit biofilm formation adding another aspect to the broad spectrum of bioactivities of cyclic dipeptides.
机译:与微生物生物膜有关的感染涉及80%的人类感染,并成为有关公共卫生的挑战。目前,与表皮葡萄球菌生物膜有关的感染通常与医疗器械有关,从而增加了这种感染的治疗费用。筛选方案中已采用消除此类疾病的替代方法,这些方案使用了多种海洋来源的真菌来源的生物活性化合物,能够对抗生物膜的形成。在这项工作中,从与海绵相关的青霉菌属sp。的二肽顺式-环(亮氨酰-酪氨酰)分离。扫描电子显微镜证实,它具有显着的抑制高达85%的生物膜形成而不会干扰细菌生长的特性。这是第一个证明顺式环(亮氨酰-酪氨酰)能够特异性抑制生物膜形成的方法,这为环状二肽的广泛生物活性增加了另一个方面。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号